Mather Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,090
| Closed | -$691K | – | 1459 |
|
|
2025
Q1 | $691K | Buy |
1,090
+183
| +20% | +$116K | 0.01% | 314 |
|
|
2024
Q4 | $646K | Sell |
907
-65
| -7% | -$46.3K | 0.01% | 300 |
|
|
2024
Q3 | $1.02M | Sell |
972
-172
| -15% | -$181K | 0.01% | 242 |
|
|
2024
Q2 | $1.1M | Buy |
1,144
+95
| +9% | +$91.5K | 0.01% | 253 |
|
|
2024
Q1 | $921K | Buy |
1,049
+4
| +0.4% | +$3.51K | 0.01% | 235 |
|
|
2023
Q4 | $918K | Sell |
1,045
-14
| -1% | -$12.3K | 0.01% | 242 |
|
|
2023
Q3 | $872K | Buy |
1,059
+127
| +14% | +$105K | 0.02% | 236 |
|
|
2023
Q2 | $669K | Buy |
932
+560
| +151% | +$402K | 0.01% | 295 |
|
|
2023
Q1 | $305K | Buy |
372
+38
| +11% | +$31.2K | 0.01% | 393 |
|
|
2022
Q4 | $241K | Buy |
334
+11
| +3% | +$7.94K | ﹤0.01% | 432 |
|
|
2022
Q3 | $222K | Buy |
+323
| New | +$222K | ﹤0.01% | 433 |
|
|
2021
Q4 | – | Sell |
-477
| Closed | -$289K | – | 396 |
|
|
2021
Q3 | $289K | Buy |
+477
| New | +$289K | 0.01% | 228 |
|